Global Biochip Market

Market Dynamics

The factors that drive growth for the Biochip Market include ever-growing applications, technological advancements being brought out in the field and the increased adoption of personalized medicine. The unclear regulatory guidelines are a major challenge for this industry. Another challenge for this industry is the high cost of instrumentation.

The market also throws up several opportunities with regard to a large number of alliances in the industry and the increasing technological research.

Market Segmentation

The market is segmented in terms of the type, application and end users.

In terms of the type, the market is classified into protein chips, DNA chips and lab-on-a-chip. A protein chip is a method used to track the interactions and activities of proteins. A DNA chip is a collection of microscopic DNA spots attached to a solid surface.

In terms of application, the market is segmented into genomics, agricultural biotechnology, SNP genotyping, drug discovery, and cancer diagnosis and treatment.

In terms of end users, the market is divided into hospitals, academic institutes, and pharmaceutical companies.

The different geographic market segments are North America, Europe, Asia Pacific and Rest of the world.

Regional/Geographic Analysis

North America is the dominating market in terms of market share due to the increasing number of geriatric population. North America is followed by Europe in terms of market share. But in terms of growth rate, Asia Pacific is the expected to be the leader because of the ongoing research activities and developing infrastructure.

Key Players

Some of the major players in the market include Thermo Fisher Scientific, GE Healthcare, Abbott Laboratories, Agilent Technologies and Cepheid Inc.

The report contains comprehensive analysis on:

Global Biochip Market Segments

Global Biochip Market Drivers, Restraints and Opportunities

Global Biochip Market Size & Forecast 2016 to 2022

Supply & Demand Value Chain

Global Biochip Market Current Trends

Competition & Major Companies

Technology and R&D Status

Porters Five Force Analysis

Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Biochip Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage